Community Oncology Connections™: Monotherapies vs Combinations – Navigating Oral SERDs and Targeted Combination Strategies in HR+/HER2- Metastatic Breast Cancer
Thursday, July 23, 2026
5:15 PM - 6:15 PM CT
This program brings together expert faculty to discuss the latest advances and enable the integration of oral SERDs and emerging combination strategies into HR+/HER2- metastatic breast cancer care.